CN Stock MarketDetailed Quotes

Shenzhen Salubris Pharmaceuticals (002294)

Watchlist
  • 58.75
  • -1.79-2.96%
Market Closed Apr 17 15:00 CST
65.50BMarket Cap97.43P/E (TTM)

Shenzhen Salubris Pharmaceuticals (002294) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
8.00%3.24B
4.32%2.13B
-2.64%1.06B
19.22%4.01B
22.18%3B
21.28%2.04B
22.92%1.09B
-3.35%3.37B
-3.61%2.46B
0.97%1.68B
Operating revenue
8.00%3.24B
4.32%2.13B
-2.64%1.06B
19.22%4.01B
22.18%3B
21.28%2.04B
22.92%1.09B
-3.35%3.37B
-3.61%2.46B
0.97%1.68B
Other operating revenue
----
36.59%55.29M
----
19.91%102.73M
----
55.31%40.48M
----
5.42%85.67M
----
22.76%26.06M
Total operating cost
8.35%2.66B
5.19%1.76B
-1.60%856.72M
18.98%3.28B
25.89%2.46B
26.52%1.67B
29.96%870.65M
-1.51%2.76B
-2.96%1.95B
-2.06%1.32B
Operating cost
-4.30%802.2M
-10.81%526.06M
-15.83%262.13M
3.78%1.1B
6.86%838.28M
12.72%589.79M
20.77%311.45M
6.44%1.06B
19.16%784.45M
25.23%523.25M
Operating tax surcharges
16.93%45.05M
14.85%29.59M
5.37%15.11M
16.78%50.87M
10.66%38.53M
1.42%25.76M
17.16%14.34M
-7.19%43.56M
-5.83%34.82M
5.89%25.4M
Operating expense
14.01%1.25B
12.90%836.37M
7.36%404.79M
45.03%1.47B
53.65%1.1B
44.24%740.8M
37.31%377.04M
-7.20%1.02B
-16.63%715.74M
-13.03%513.58M
Administration expense
6.22%208.88M
4.40%139.57M
-1.82%70.31M
-5.13%271.87M
-5.66%196.64M
1.76%133.69M
11.80%71.61M
20.64%286.59M
8.03%208.43M
2.69%131.37M
Financial expense
51.92%-11.01M
57.97%-8.79M
67.04%-3.75M
40.20%-32.16M
52.47%-22.9M
43.11%-20.92M
30.14%-11.37M
48.98%-53.78M
48.78%-48.18M
35.44%-36.77M
-Interest expense (Financial expense)
16.68%14.19M
18.98%9.31M
9.99%4.35M
-6.90%16.17M
-12.10%12.16M
-11.35%7.83M
-8.25%3.95M
38.55%17.37M
87.39%13.84M
230.16%8.83M
-Interest Income (Financial expense)
19.32%-32.11M
21.84%-21.69M
34.86%-9.91M
31.44%-47.06M
30.11%-39.8M
29.60%-27.75M
23.89%-15.22M
39.15%-68.64M
36.91%-56.95M
27.40%-39.42M
Research and development
18.40%362.89M
16.31%235.26M
0.52%108.14M
2.94%421.24M
19.59%306.48M
23.15%202.28M
38.95%107.58M
-23.34%409.19M
-28.48%256.28M
-33.09%164.25M
Credit Impairment Loss
-87.33%-13.21M
-72.45%-13.84M
-5,647.54%-1.8M
-166.54%-6.44M
36.23%-7.05M
29.59%-8.03M
-1,004.39%-31.35K
-157.89%-2.42M
-301.99%-11.06M
-318.55%-11.4M
Asset Impairment Loss
113.07%2.49M
139.94%3.16M
100.38%19.52K
-238.13%-197.99M
-266.55%-19.03M
-613.37%-7.9M
---5.07M
-3.23%-58.55M
-87.13%-5.19M
60.27%-1.11M
Other net revenue
110.46%78.86M
57.77%48.46M
94.19%24.79M
-269.62%-83.68M
-26.97%37.47M
-0.17%30.71M
-50.53%12.77M
6.55%49.33M
-41.62%51.31M
-59.67%30.77M
Fair value change income
-3.11%7.67M
6.46%5.73M
91.37%2.82M
79.33%14.51M
21.16%7.92M
1.47%5.39M
-56.32%1.47M
112.34%8.09M
--6.53M
--5.31M
Invest income
199.39%36.06M
199.98%19.61M
494.33%7.32M
168.59%33.03M
1,468.66%12.05M
46.12%6.54M
32.90%1.23M
-68.03%12.3M
-98.15%767.87K
-89.47%4.47M
-Including: Investment income associates
58.77%-4.95M
73.40%-2.67M
35.67%-4.19M
66.74%-5.14M
17.89%-12M
-66.71%-10.03M
-64.27%-6.51M
-154.60%-15.46M
-411.45%-14.61M
-252.49%-6.02M
Asset deal income
-452.06%-1.01M
-4,600.98%-983.77K
97.14%-609.64
68.89%-148.63K
176.28%285.89K
94.41%-20.93K
94.70%-21.34K
-162.13%-477.67K
-35.22%-374.77K
-70.38%-374.52K
Other revenue
8.20%46.86M
0.13%34.78M
8.23%16.44M
-18.84%73.36M
-28.58%43.31M
2.57%34.73M
-30.68%15.19M
59.25%90.39M
37.86%60.64M
7.28%33.86M
Operating profit
13.16%658.32M
4.83%421.36M
-1.21%230.28M
-1.47%646.31M
4.62%581.77M
2.02%401.95M
-4.24%233.09M
-9.82%655.98M
-11.06%556.08M
-0.42%393.98M
Add:Non operating Income
374.37%886.45K
648.30%543.33K
124.51%34.14K
14.62%2.16M
-74.40%186.87K
-86.24%72.61K
-87.83%15.21K
0.29%1.88M
-25.25%730.1K
-38.55%527.7K
Less:Non operating expense
10.91%8.51M
2.22%5.29M
-0.89%2.35M
-0.91%15.95M
11.93%7.67M
75.51%5.18M
58.23%2.37M
3.27%16.1M
-46.47%6.85M
-66.20%2.95M
Total profit
13.31%650.7M
4.98%416.61M
-1.20%227.96M
-1.44%632.52M
4.42%574.29M
1.35%396.85M
-4.67%230.73M
-10.08%641.76M
-10.34%549.96M
0.98%391.56M
Less:Income tax cost
-4.66%59.3M
-21.52%41.24M
-23.06%25.1M
-55.10%27.36M
-14.52%62.2M
-5.77%52.55M
-2.15%32.62M
-23.22%60.93M
-3.02%72.77M
38.11%55.76M
Net profit
15.49%591.39M
9.02%375.37M
2.40%202.86M
4.19%605.16M
7.31%512.09M
2.53%344.3M
-5.07%198.11M
-8.44%580.83M
-11.36%477.19M
-3.34%335.79M
Net profit from continuing operation
15.49%591.39M
9.02%375.37M
2.40%202.86M
4.19%605.16M
7.31%512.09M
2.53%344.3M
-5.07%198.11M
-8.44%580.83M
-11.36%477.19M
-3.34%335.79M
Less:Minority Profit
350.04%10.69M
4,875.29%10.29M
217.53%2.53M
370.38%3.59M
219.85%2.37M
111.29%206.84K
4.41%-2.15M
127.97%762.47K
-54.81%-1.98M
-124.95%-1.83M
Net profit of parent company owners
13.93%580.71M
6.10%365.08M
0.03%200.33M
3.71%601.57M
6.37%509.71M
1.92%344.09M
-5.06%200.27M
-8.95%580.07M
-11.20%479.17M
-3.04%337.62M
Earning per share
Basic earning per share
13.04%0.52
6.45%0.33
0.00%0.18
3.85%0.54
6.98%0.46
3.33%0.31
-5.26%0.18
-10.34%0.52
-12.24%0.43
-3.23%0.3
Diluted earning per share
13.04%0.52
6.45%0.33
0.00%0.18
3.85%0.54
6.98%0.46
3.33%0.31
-5.26%0.18
-10.34%0.52
-12.24%0.43
-3.23%0.3
Other composite income
71.62%-1.72M
38.87%3.95M
-341.92%-1.45M
-32.35%7.13M
-139.43%-6.07M
-84.71%2.84M
107.70%600.42K
-77.40%10.55M
-71.29%15.4M
-22.78%18.61M
Other composite income of parent company owners
55.64%-2.69M
4.79%2.98M
-341.92%-1.45M
-31.85%7.08M
-139.43%-6.07M
-84.71%2.84M
107.70%600.42K
-77.74%10.39M
-71.29%15.4M
-22.78%18.61M
Other composite income of minority owners
--969.77K
--969.77K
----
-65.09%56.13K
----
----
----
--160.79K
----
----
Total composite income
16.53%589.67M
9.27%379.32M
1.36%201.41M
3.54%612.29M
2.73%506.02M
-2.05%347.14M
-1.09%198.71M
-13.16%591.37M
-16.79%492.59M
-4.60%354.4M
Total composite income of parent company owners
14.77%578.01M
6.09%368.06M
-0.99%198.88M
3.08%608.65M
1.83%503.64M
-2.61%346.94M
-1.12%200.87M
-13.64%590.45M
-16.63%494.57M
-4.31%356.23M
Total composite income of minority owners
390.88%11.66M
5,344.13%11.26M
217.53%2.53M
294.54%3.64M
219.85%2.37M
111.29%206.84K
4.41%-2.15M
133.87%923.26K
-54.81%-1.98M
-124.95%-1.83M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 8.00%3.24B4.32%2.13B-2.64%1.06B19.22%4.01B22.18%3B21.28%2.04B22.92%1.09B-3.35%3.37B-3.61%2.46B0.97%1.68B
Operating revenue 8.00%3.24B4.32%2.13B-2.64%1.06B19.22%4.01B22.18%3B21.28%2.04B22.92%1.09B-3.35%3.37B-3.61%2.46B0.97%1.68B
Other operating revenue ----36.59%55.29M----19.91%102.73M----55.31%40.48M----5.42%85.67M----22.76%26.06M
Total operating cost 8.35%2.66B5.19%1.76B-1.60%856.72M18.98%3.28B25.89%2.46B26.52%1.67B29.96%870.65M-1.51%2.76B-2.96%1.95B-2.06%1.32B
Operating cost -4.30%802.2M-10.81%526.06M-15.83%262.13M3.78%1.1B6.86%838.28M12.72%589.79M20.77%311.45M6.44%1.06B19.16%784.45M25.23%523.25M
Operating tax surcharges 16.93%45.05M14.85%29.59M5.37%15.11M16.78%50.87M10.66%38.53M1.42%25.76M17.16%14.34M-7.19%43.56M-5.83%34.82M5.89%25.4M
Operating expense 14.01%1.25B12.90%836.37M7.36%404.79M45.03%1.47B53.65%1.1B44.24%740.8M37.31%377.04M-7.20%1.02B-16.63%715.74M-13.03%513.58M
Administration expense 6.22%208.88M4.40%139.57M-1.82%70.31M-5.13%271.87M-5.66%196.64M1.76%133.69M11.80%71.61M20.64%286.59M8.03%208.43M2.69%131.37M
Financial expense 51.92%-11.01M57.97%-8.79M67.04%-3.75M40.20%-32.16M52.47%-22.9M43.11%-20.92M30.14%-11.37M48.98%-53.78M48.78%-48.18M35.44%-36.77M
-Interest expense (Financial expense) 16.68%14.19M18.98%9.31M9.99%4.35M-6.90%16.17M-12.10%12.16M-11.35%7.83M-8.25%3.95M38.55%17.37M87.39%13.84M230.16%8.83M
-Interest Income (Financial expense) 19.32%-32.11M21.84%-21.69M34.86%-9.91M31.44%-47.06M30.11%-39.8M29.60%-27.75M23.89%-15.22M39.15%-68.64M36.91%-56.95M27.40%-39.42M
Research and development 18.40%362.89M16.31%235.26M0.52%108.14M2.94%421.24M19.59%306.48M23.15%202.28M38.95%107.58M-23.34%409.19M-28.48%256.28M-33.09%164.25M
Credit Impairment Loss -87.33%-13.21M-72.45%-13.84M-5,647.54%-1.8M-166.54%-6.44M36.23%-7.05M29.59%-8.03M-1,004.39%-31.35K-157.89%-2.42M-301.99%-11.06M-318.55%-11.4M
Asset Impairment Loss 113.07%2.49M139.94%3.16M100.38%19.52K-238.13%-197.99M-266.55%-19.03M-613.37%-7.9M---5.07M-3.23%-58.55M-87.13%-5.19M60.27%-1.11M
Other net revenue 110.46%78.86M57.77%48.46M94.19%24.79M-269.62%-83.68M-26.97%37.47M-0.17%30.71M-50.53%12.77M6.55%49.33M-41.62%51.31M-59.67%30.77M
Fair value change income -3.11%7.67M6.46%5.73M91.37%2.82M79.33%14.51M21.16%7.92M1.47%5.39M-56.32%1.47M112.34%8.09M--6.53M--5.31M
Invest income 199.39%36.06M199.98%19.61M494.33%7.32M168.59%33.03M1,468.66%12.05M46.12%6.54M32.90%1.23M-68.03%12.3M-98.15%767.87K-89.47%4.47M
-Including: Investment income associates 58.77%-4.95M73.40%-2.67M35.67%-4.19M66.74%-5.14M17.89%-12M-66.71%-10.03M-64.27%-6.51M-154.60%-15.46M-411.45%-14.61M-252.49%-6.02M
Asset deal income -452.06%-1.01M-4,600.98%-983.77K97.14%-609.6468.89%-148.63K176.28%285.89K94.41%-20.93K94.70%-21.34K-162.13%-477.67K-35.22%-374.77K-70.38%-374.52K
Other revenue 8.20%46.86M0.13%34.78M8.23%16.44M-18.84%73.36M-28.58%43.31M2.57%34.73M-30.68%15.19M59.25%90.39M37.86%60.64M7.28%33.86M
Operating profit 13.16%658.32M4.83%421.36M-1.21%230.28M-1.47%646.31M4.62%581.77M2.02%401.95M-4.24%233.09M-9.82%655.98M-11.06%556.08M-0.42%393.98M
Add:Non operating Income 374.37%886.45K648.30%543.33K124.51%34.14K14.62%2.16M-74.40%186.87K-86.24%72.61K-87.83%15.21K0.29%1.88M-25.25%730.1K-38.55%527.7K
Less:Non operating expense 10.91%8.51M2.22%5.29M-0.89%2.35M-0.91%15.95M11.93%7.67M75.51%5.18M58.23%2.37M3.27%16.1M-46.47%6.85M-66.20%2.95M
Total profit 13.31%650.7M4.98%416.61M-1.20%227.96M-1.44%632.52M4.42%574.29M1.35%396.85M-4.67%230.73M-10.08%641.76M-10.34%549.96M0.98%391.56M
Less:Income tax cost -4.66%59.3M-21.52%41.24M-23.06%25.1M-55.10%27.36M-14.52%62.2M-5.77%52.55M-2.15%32.62M-23.22%60.93M-3.02%72.77M38.11%55.76M
Net profit 15.49%591.39M9.02%375.37M2.40%202.86M4.19%605.16M7.31%512.09M2.53%344.3M-5.07%198.11M-8.44%580.83M-11.36%477.19M-3.34%335.79M
Net profit from continuing operation 15.49%591.39M9.02%375.37M2.40%202.86M4.19%605.16M7.31%512.09M2.53%344.3M-5.07%198.11M-8.44%580.83M-11.36%477.19M-3.34%335.79M
Less:Minority Profit 350.04%10.69M4,875.29%10.29M217.53%2.53M370.38%3.59M219.85%2.37M111.29%206.84K4.41%-2.15M127.97%762.47K-54.81%-1.98M-124.95%-1.83M
Net profit of parent company owners 13.93%580.71M6.10%365.08M0.03%200.33M3.71%601.57M6.37%509.71M1.92%344.09M-5.06%200.27M-8.95%580.07M-11.20%479.17M-3.04%337.62M
Earning per share
Basic earning per share 13.04%0.526.45%0.330.00%0.183.85%0.546.98%0.463.33%0.31-5.26%0.18-10.34%0.52-12.24%0.43-3.23%0.3
Diluted earning per share 13.04%0.526.45%0.330.00%0.183.85%0.546.98%0.463.33%0.31-5.26%0.18-10.34%0.52-12.24%0.43-3.23%0.3
Other composite income 71.62%-1.72M38.87%3.95M-341.92%-1.45M-32.35%7.13M-139.43%-6.07M-84.71%2.84M107.70%600.42K-77.40%10.55M-71.29%15.4M-22.78%18.61M
Other composite income of parent company owners 55.64%-2.69M4.79%2.98M-341.92%-1.45M-31.85%7.08M-139.43%-6.07M-84.71%2.84M107.70%600.42K-77.74%10.39M-71.29%15.4M-22.78%18.61M
Other composite income of minority owners --969.77K--969.77K-----65.09%56.13K--------------160.79K--------
Total composite income 16.53%589.67M9.27%379.32M1.36%201.41M3.54%612.29M2.73%506.02M-2.05%347.14M-1.09%198.71M-13.16%591.37M-16.79%492.59M-4.60%354.4M
Total composite income of parent company owners 14.77%578.01M6.09%368.06M-0.99%198.88M3.08%608.65M1.83%503.64M-2.61%346.94M-1.12%200.87M-13.64%590.45M-16.63%494.57M-4.31%356.23M
Total composite income of minority owners 390.88%11.66M5,344.13%11.26M217.53%2.53M294.54%3.64M219.85%2.37M111.29%206.84K4.41%-2.15M133.87%923.26K-54.81%-1.98M-124.95%-1.83M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More